Wednesday, September 4, 2024

  • 09/04/2024 - 12:00pm to 1:00pm
    Learn about new molecular classification of tumors Learn about new ways to target tumors Learn about targeted approach to vascular malformations, neurofibromatosis and other benign hematologic disorders